申请人:ASTRAZENECA AB
公开号:WO2000073312A1
公开(公告)日:2000-12-07
There are provided novel compounds of formula (I), wherein R1, R2, A, Q and X are as defined in the specification, and optical isomers, racemates and tautomers thereof and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the enzyme nitric oxide synthase.